Clinical Characteristics and Long-term Management for Patients with Vitamin D-dependent Rickets Type II: a Retrospective Study at a Single Center in Saudi Arabia

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Jun 14

PMID 38872968

Authors

Afaf Alsagheir

Abdullah Al-Ashwal

Amal Binladen

Raghad Alhuthil

Faisal Joueidi

Khushnooda Ramzan

Faiqa Imtiaz

Affiliations

Soon will be listed here.

Abstract

Introduction: Hereditary Vitamin D-dependent rickets type II (HVDDR-type II) is a rare autosomal recessive disorder caused by molecular variation in the gene encoding the vitamin D receptor (VDR). This study aims to evaluate phenotype and genotype characteristics and long-term follow-up of the largest group of patients with (HVDDR-type II) in Saudi Arabia.

Methodology: We conducted a retrospective chart review to collect the clinical, biochemical, and genetic data for all HVDDR-type II patients currently receiving treatment at King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Results: A total of 42 patients, 57.1% female, and 42.9% male were included in the study. Seven patients were treated with high doses of oral calcium, while 35 patients were treated with IV calcium infusion. The median age at presentation was 15.5 months. Alopecia was found in 97.6%, 21.4% presented with bowing legs, 14.3% with delayed walking, 9.5% with seizure, and 2.4% presented with respiratory failure, while a family history of the disease was positive in 71.4% of total patients. Molecular genetic testing of the VDR gene in our cohort identified six different gene variants c.885 C>A (p.Tyr295Ter), c.88 C>T (p.Arg30Ter), c.1036G>A (p.Val346Met), c.820C>T (p.Arg274Cys), c.803 T>C (p.Ile268Thr), and c.2T>G (p.Met1?).

Conclusion: We are describing the largest cohort of patients with HVDDR-type II, their clinical biochemical findings, and the most prevalent genetic variants in our population.

References

Lin J, Uttley W . Intra-atrial calcium infusions, growth, and development in end organ resistance to vitamin D. Arch Dis Child. 1993; 69(6):689-92. PMC: 1029657. DOI: 10.1136/adc.69.6.689. View

Arita K, Nanda A, Wessagowit V, Akiyama M, Alsaleh Q, McGrath J . A novel mutation in the VDR gene in hereditary vitamin D-resistant rickets. Br J Dermatol. 2007; 158(1):168-71. DOI: 10.1111/j.1365-2133.2007.08232.x. View

El-Mouzan M, Al-Herbish A, Al-Salloum A, Qurachi M, Al-Omar A . Growth charts for Saudi children and adolescents. Saudi Med J. 2007; 28(10):1555-68. View

Nicolaidou P, Tsitsika A, Papadimitriou A, Karantana A, Papadopoulou A, Psychou F . Hereditary vitamin D-resistant rickets in Greek children: genotype, phenotype, and long-term response to treatment. J Pediatr Endocrinol Metab. 2007; 20(3):425-30. DOI: 10.1515/jpem.2007.20.3.425. View

Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K . A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997; 12(6):915-21. DOI: 10.1359/jbmr.1997.12.6.915. View

Aljubeh J, Wang J, Al-Remeithi S, J Malloy P, Feldman D . Report of two unrelated patients with hereditary vitamin D resistant rickets due to the same novel mutation in the vitamin D receptor. J Pediatr Endocrinol Metab. 2011; 24(9-10):793-9. DOI: 10.1515/jpem.2011.341. View

J Malloy P, Feldman D . The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol. 2011; 347(1-2):90-6. PMC: 3196847. DOI: 10.1016/j.mce.2011.05.045. View

Al-Aqeel A, OZAND P, Sobki S, Sewairi W, Marx S . The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII). Clin Endocrinol (Oxf). 1993; 39(2):229-37. DOI: 10.1111/j.1365-2265.1993.tb01779.x. View

Ma N, J Malloy P, Pitukcheewanont P, Dreimane D, Geffner M, Feldman D . Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy. Bone. 2009; 45(4):743-6. PMC: 2782671. DOI: 10.1016/j.bone.2009.06.003. View

10.

Chanchlani R, Nemer P, Sinha R, Nemer L, Krishnappa V, Sochett E . An Overview of Rickets in Children. Kidney Int Rep. 2020; 5(7):980-990. PMC: 7335963. DOI: 10.1016/j.ekir.2020.03.025. View

11.

Ersoy B, Kiremitci S, Isojima T, Kitanaka S . Successful intermittent intravenous calcium treatment via the peripheral route in a patient with hereditary vitamin D-resistant rickets and alopecia. Horm Res Paediatr. 2015; 83(1):67-72. DOI: 10.1159/000367711. View

12.

Mazen I, Ismail S, Amr K, Gammal M, Abdel-Hamid M . Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene. J Pediatr Endocrinol Metab. 2014; 27(9-10):873-8. DOI: 10.1515/jpem-2013-0443. View

13.

Mechica J, Leite M, Mendonca B, Frazzatto E, Borelli A, Latronico A . A novel nonsense mutation in the first zinc finger of the vitamin D receptor causing hereditary 1,25-dihydroxyvitamin D3-resistant rickets. J Clin Endocrinol Metab. 1997; 82(11):3892-4. DOI: 10.1210/jcem.82.11.4384. View

14.

Sunuwar N, Gautam S, Twayana A, Adhikari Yadav S, Anjum F, Kandel K . Hereditary Vitamin-D Dependent Rickets Type II: A Case Report. JNMA J Nepal Med Assoc. 2021; 59(238):597-600. PMC: 8369553. DOI: 10.31729/jnma.6411. View

15.

Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T . Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003; 144(12):5138-44. DOI: 10.1210/en.2003-0502. View

16.

Ritchie H, Hughes M, Thompson E, Malloy P, Hochberg Z, Feldman D . An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families. Proc Natl Acad Sci U S A. 1989; 86(24):9783-7. PMC: 298586. DOI: 10.1073/pnas.86.24.9783. View

17.

Ameur S, Silve C, Chabchoub I, Damak F, Kamoun F, Toussaint A . Clinical and Genetic Characterization of Tunisian Children with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets. Horm Res Paediatr. 2016; 87(1):23-29. DOI: 10.1159/000452886. View

18.

Weber G, Cazzuffi M, Frisone F, De Angelis M, Pasolini D, Tomaselli V . Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol. Child Nephrol Urol. 1988; 9(5):273-6. View

19.

J Malloy P, Xu R, Peng L, Peleg S, Al-Ashwal A, Feldman D . Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Endocrinology. 2004; 145(11):5106-14. DOI: 10.1210/en.2004-0080. View

20.

Bayramoglu E, Savas Erdeve S, Shi Y, Keskin M, Cetinkaya S, Kurnaz E . Experience of intravenous calcium treatment and long-term responses to treatment in a patient with hereditary vitamin D-resistant rickets resulting from a novel mutation. J Pediatr Endocrinol Metab. 2019; 32(6):647-651. DOI: 10.1515/jpem-2018-0399. View